Evaluation of Ocular Surface Tumors Using Anterior Segment Optical Coherence Tomography (OCT)
NCT ID: NCT06808126
Last Updated: 2025-02-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
58 participants
OBSERVATIONAL
2025-03-01
2026-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
and recommended as a rapid, informative and quite reliable method of examination to differentiate benign from malignant ocular surface tumors.
The conjunctiva is an anatomical site with a prominent risk of squamous cell carcinoma development, which is a unique biological behavior. The superficial lesion with significant epithelial cell growth usually displays unique data, contributing to unusual ocular tumors.
Anterior segment optical coherence tomography (AS-OCT), as a noninvasive, high-resolution imaging technique, provides crucial morphological and anatomical information in ocular surface tumors via visualizing the layer structure of the cornea and anterior segment, qualifying tumor morphology, and quantifying thickness and extension. AS-OCT can provide valuable information for helping in clinical diagnoses, differential diagnoses, prognoses, and evaluating responses to treatments as a significant imaging tool in ocular surface tumors.
The correct diagnosis and classification of ocular surface tumors are crucial aspects of their proper management.
the aim of the study • To evaluate the imaging characteristics of ocular surface tumors on high-resolution anterior segment optical coherence tomography (ASOCT).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quantitative Assessment of Lid Margin Vascularity Using SS-OCTA
NCT06091722
Objective Choroidal Thickness Measurements in Uveitis
NCT03889860
Evaluation of Retinal Structure With High Resolution Optical Coherence Tomography (OCT)
NCT00564291
Blood Vessel Patterns in Small Choroidal Tumors
NCT01955915
Spectral-domain Optical Coherence Tomography of the Eye
NCT02614625
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
and recommended as a rapid, informative and quite reliable method of examination to differentiate benign from malignant ocular surface tumors.
The conjunctiva is an anatomical site with a prominent risk of squamous cell carcinoma development, which is a unique biological behavior. The superficial lesion with significant epithelial cell growth usually displays unique data, contributing to unusual ocular tumors.
Anterior segment optical coherence tomography (AS-OCT), as a noninvasive, high-resolution imaging technique, provides crucial morphological and anatomical information in ocular surface tumors via visualizing the layer structure of the cornea and anterior segment, qualifying tumor morphology, and quantifying thickness and extension. AS-OCT can provide valuable information for helping in clinical diagnoses, differential diagnoses, prognoses, and evaluating responses to treatments as a significant imaging tool in ocular surface tumors.
The correct diagnosis and classification of ocular surface tumors are crucial aspects of their proper management.
the aim of the study • To evaluate the imaging characteristics of ocular surface tumors on high-resolution anterior segment optical coherence tomography (ASOCT).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ocular Surface Tumors
patients presented with ocular surface lesion suspected to be neoplastic
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amira Mohamed Abdelrahman Gebaly
residant doctor
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Ocular Surface Tumors by OCT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.